Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × Brentuximab Vedotin × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Mycosis Fungoides 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Melanoma 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hematologic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 38 fludarabine 24 Methotrexate 21 Vincristine 20 Cytarabine 18 fludarabine phosphate 17 blinatumomab 17 Dexamethasone 16 venetoclax 11 Melphalan 11 Granulocyte Colony-Stimulating Factor 11 Whole-Body Irradiation 10 Mycophenolic Acid 10 Mercaptopurine 10 Tacrolimus 9 Hydrocortisone 9 Filgrastim 9 Stem Cell Transplantation 8 Rituximab 8 Mesna 8 Etoposide 8 Doxorubicin 8 Calcium Dobesilate 8 Busulfan 8 pegaspargase 7 merphos 7 calaspargase pegol 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 ponatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡